Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 31

1.

Impact of Molecular Crowding on Translational Mobility and Conformational Properties of Biological Macromolecules.

Junker NO, Vaghefikia F, Albarghash A, Höfig H, Kempe D, Walter J, Otten J, Pohl M, Katranidis A, Wiegand S, Fitter J.

J Phys Chem B. 2019 May 30;123(21):4477-4486. doi: 10.1021/acs.jpcb.9b01239. Epub 2019 May 15.

PMID:
31059260
2.

Exploring the mechanisms underlying the social identity-ill-health link: Longitudinal and experimental evidence.

Junker NM, van Dick R, Avanzi L, Häusser JA, Mojzisch A.

Br J Soc Psychol. 2019 Oct;58(4):991-1007. doi: 10.1111/bjso.12308. Epub 2018 Dec 18.

PMID:
30561049
3.

Scalable Fabrication of Nanostructured Tin Oxide Anodes for High-Energy Lithium-Ion Batteries.

Heubner C, Liebmann T, Voigt K, Weiser M, Matthey B, Junker N, Lämmel C, Schneider M, Michaelis A.

ACS Appl Mater Interfaces. 2018 Aug 15;10(32):27019-27029. doi: 10.1021/acsami.8b07981. Epub 2018 Aug 2.

PMID:
30028127
4.

PD-L1 peptide co-stimulation increases immunogenicity of a dendritic cell-based cancer vaccine.

Munir Ahmad S, Martinenaite E, Hansen M, Junker N, Borch TH, Met Ö, Donia M, Svane IM, Andersen MH.

Oncoimmunology. 2016 Jul 1;5(8):e1202391. doi: 10.1080/2162402X.2016.1202391. eCollection 2016 Aug.

5.

Hypoxia-Inducible Factor-1α Expression in Macrophages Promotes Development of Atherosclerosis.

Aarup A, Pedersen TX, Junker N, Christoffersen C, Bartels ED, Madsen M, Nielsen CH, Nielsen LB.

Arterioscler Thromb Vasc Biol. 2016 Sep;36(9):1782-90. doi: 10.1161/ATVBAHA.116.307830. Epub 2016 Jul 21.

PMID:
27444197
6.

Schwann Cell Expressed Nogo-B Modulates Axonal Branching of Adult Sensory Neurons Through the Nogo-B Receptor NgBR.

Eckharter C, Junker N, Winter L, Fischer I, Fogli B, Kistner S, Pfaller K, Zheng B, Wiche G, Klimaschewski L, Schweigreiter R.

Front Cell Neurosci. 2015 Nov 23;9:454. doi: 10.3389/fncel.2015.00454. eCollection 2015.

7.

Osteopontin deficiency dampens the pro-atherogenic effect of uraemia.

Pedersen TX, Madsen M, Junker N, Christoffersen C, Vikeså J, Bro S, Hultgårdh-Nilsson A, Nielsen LB.

Cardiovasc Res. 2013 Jun 1;98(3):352-9. doi: 10.1093/cvr/cvt049. Epub 2013 Mar 1.

PMID:
23455547
8.

Adoptive cell therapy with autologous tumor infiltrating lymphocytes and low-dose Interleukin-2 in metastatic melanoma patients.

Ellebaek E, Iversen TZ, Junker N, Donia M, Engell-Noerregaard L, Met Ö, Hölmich LR, Andersen RS, Hadrup SR, Andersen MH, thor Straten P, Svane IM.

J Transl Med. 2012 Aug 21;10:169. doi: 10.1186/1479-5876-10-169.

9.

Interaction between VEGF and calcium-independent phospholipase A2 in proliferation and migration of retinal pigment epithelium.

Kehler AK, Andersen C, Andreasen JR, Vohra R, Junker N, Poulsen KA, Kolko M.

Curr Eye Res. 2012 Jun;37(6):500-7. doi: 10.3109/02713683.2012.663855.

PMID:
22577768
10.

A promiscuous survivin-derived T-cell epitope restricted to the HLA-A3 super-type alleles.

Junker N, Munir S, Kvistborg P, Straten Pt, Svane IM, Andersen MH.

J Invest Dermatol. 2012 Aug;132(8):2115-8. doi: 10.1038/jid.2012.109. Epub 2012 Apr 19. No abstract available.

11.

Dissection of T-cell antigen specificity in human melanoma.

Andersen RS, Thrue CA, Junker N, Lyngaa R, Donia M, Ellebæk E, Svane IM, Schumacher TN, Thor Straten P, Hadrup SR.

Cancer Res. 2012 Apr 1;72(7):1642-50. doi: 10.1158/0008-5472.CAN-11-2614. Epub 2012 Feb 6.

12.

Tumor associated antigen specific T-cell populations identified in ex vivo expanded TIL cultures.

Junker N, Kvistborg P, Køllgaard T, Straten Pt, Andersen MH, Svane IM.

Cell Immunol. 2012;273(1):1-9. doi: 10.1016/j.cellimm.2011.12.004. Epub 2011 Dec 17.

PMID:
22230732
13.

Characterization and comparison of 'standard' and 'young' tumour-infiltrating lymphocytes for adoptive cell therapy at a Danish translational research institution.

Donia M, Junker N, Ellebaek E, Andersen MH, Straten PT, Svane IM.

Scand J Immunol. 2012 Feb;75(2):157-67. doi: 10.1111/j.1365-3083.2011.02640.x.

14.

Characterization of ex vivo expanded tumor infiltrating lymphocytes from patients with malignant melanoma for clinical application.

Junker N, Thor Straten P, Andersen MH, Svane IM.

J Skin Cancer. 2011;2011:574695. doi: 10.1155/2011/574695. Epub 2011 Jun 18.

15.

Bimodal ex vivo expansion of T cells from patients with head and neck squamous cell carcinoma: a prerequisite for adoptive cell transfer.

Junker N, Andersen MH, Wenandy L, Dombernowsky SL, Kiss K, Sørensen CH, Therkildsen MH, Von Buchwald C, Andersen E, Straten PT, Svane IM.

Cytotherapy. 2011 Aug;13(7):822-34. doi: 10.3109/14653249.2011.563291. Epub 2011 Mar 24.

PMID:
21428850
16.

Therapeutic cancer vaccines in combination with conventional therapy.

Andersen MH, Junker N, Ellebaek E, Svane IM, Thor Straten P.

J Biomed Biotechnol. 2010;2010:237623. doi: 10.1155/2010/237623. Epub 2010 Jun 29. Review.

17.

The immune system strikes back: cellular immune responses against indoleamine 2,3-dioxygenase.

Sørensen RB, Berge-Hansen L, Junker N, Hansen CA, Hadrup SR, Schumacher TN, Svane IM, Becker JC, thor Straten P, Andersen MH.

PLoS One. 2009 Sep 7;4(9):e6910. doi: 10.1371/journal.pone.0006910.

18.

The immunodominant HLA-A2-restricted MART-1 epitope is not presented on the surface of many melanoma cell lines.

Sørensen RB, Junker N, Kirkin A, Voigt H, Svane IM, Becker JC, thor Straten P, Andersen MH.

Cancer Immunol Immunother. 2009 May;58(5):665-75. doi: 10.1007/s00262-008-0588-0. Epub 2008 Oct 1.

PMID:
18828018
19.

Hypoxia-induced secretion of macrophage migration-inhibitory factor from MCF-7 breast cancer cells is regulated in a hypoxia-inducible factor-independent manner.

Larsen M, Tazzyman S, Lund EL, Junker N, Lewis CE, Kristjansen PE, Murdoch C.

Cancer Lett. 2008 Jul 8;265(2):239-49. doi: 10.1016/j.canlet.2008.02.012. Epub 2008 Mar 18.

PMID:
18353538
20.

YKL-40 expression in benign and malignant lesions of the breast: a methodologic study.

Roslind A, Johansen JS, Junker N, Nielsen DL, Dzaferi H, Price PA, Balslev E.

Appl Immunohistochem Mol Morphol. 2007 Dec;15(4):371-81.

PMID:
18091378
21.

[Biphosphonates in breast cancer--based on a Cochrane meta-analysis].

Junker N, Nielsen DL, Kamby C.

Ugeskr Laeger. 2007 Sep 10;169(37):3108-11. Review. Danish. No abstract available.

PMID:
17877961
22.

Angiopoietin-4 inhibits angiogenesis and reduces interstitial fluid pressure.

Olsen MW, Ley CD, Junker N, Hansen AJ, Lund EL, Kristjansen PE.

Neoplasia. 2006 May;8(5):364-72.

23.

Expression of YKL-40 by peritumoral macrophages in human small cell lung cancer.

Junker N, Johansen JS, Andersen CB, Kristjansen PE.

Lung Cancer. 2005 May;48(2):223-31. Epub 2005 Jan 8.

PMID:
15829322
24.

Regulation of YKL-40 expression during genotoxic or microenvironmental stress in human glioblastoma cells.

Junker N, Johansen JS, Hansen LT, Lund EL, Kristjansen PE.

Cancer Sci. 2005 Mar;96(3):183-90.

25.

Expression and regulation patterns of hyaluronidases in small cell lung cancer and glioma lines.

Junker N, Latini S, Petersen LN, Kristjansen PE.

Oncol Rep. 2003 May-Jun;10(3):609-16.

PMID:
12684632
26.

Superantigen presentation by human retinal pigment epithelial cells to T cells is dependent on CD2-CD58 and CD18-CD54 molecule interactions.

Jørgensen A, Junker N, Kaestel CG, Liang Y, Wiencke A, la Cour M, Lui GM, Ødum N, Nissen MH, Röpke C.

Exp Eye Res. 2001 Nov;73(5):723-33.

PMID:
11747372
27.
28.

In vivo observation of cell division of anaerobic hyperthermophiles by using a high-intensity dark-field microscope.

Horn C, Paulmann B, Kerlen G, Junker N, Huber H.

J Bacteriol. 1999 Aug;181(16):5114-8.

29.

[The orientation of the head in the cephalostat during the recording of cephalographs of the face (posterior-anterior axis)].

Fischer-Brandies H, Junker N, Engel G.

Orthod Fr. 1986;57 Pt 2:643-9. French. No abstract available.

PMID:
3267781
30.

[Theory and practice of functional orthodontic treatment in infants and young children with Down's disease].

Fischer-Brandies H, Junker N.

Orthod Fr. 1985;56(2):365-9. French. No abstract available.

PMID:
2949190
31.

[Theory and practice of functional orthodontic treatment in infants and young children with Down's disease].

Fischer-Brandies H, Junker N.

Orthod Fr. 1984;55(2):467-71. French. No abstract available.

PMID:
6242499

Supplemental Content

Loading ...
Support Center